Home Tags EpiPen

Tag: EpiPen

Law

Five Plaintiffs’ Firms Are Seeking $88M For EpiPen Class Action

Five plaintiffs' firms are seeking $88 million in legal fees for their lead roles in a $264 million class action antitrust settlement in a...
EpiPen

EpiPen Antitrust Suit Settled For $264M

Viatris, the drugmaker formerly known as Mylan, said on Monday it had agreed to pay $264 million to resolve a class action lawsuit alleging...
pfizer

US Court OKs Pfizer’s $345M EpiPen Settlement

The EpiPen buyers leading price-gouging litigation against two top drugmakers secured final approval Wednesday from a federal judge in Kansas for their $345 million...
Can Identical Products, Bundled Together, Constitute Illegal Tying?

Can Identical Products, Bundled Together, Constitute Illegal Tying?

Can bundling identical items constitute anticompetitive behavior? Unlawful tying occurs when a seller has market control and essentially forces the buyer to purchase another...
Bundling Identical Products: An Economic Analysis

Bundling Identical Products: An Economic Analysis

This article considers whether or not the bundling of two identical products is usefully treated as a tying arrangement. Following Prof. Williams’ article in...
EpiPen

Mylan Wins Dismissal Of EpiPen Direct Purchaser Case

Viatris announced that the US District Court for the District of Kansas granted Mylan's motion to dismiss in a lawsuit brought against it and Pfizer...
pfizer

Pfizer Pays To Exit EpiPen Price-Gouging Case

Pfizer and two subsidiaries will pay $345 million to escape antitrust litigation over an alleged scheme to gouge purchasers of the EpiPen, a lifesaving...
EpiPen

Viatris Gets A Win In Long-Running EpiPen Antitrust Suit 

According to FiercePharma, Viatris, the drugmaker announced that it's scored a win against serious charges in an antitrust case that's been running for several...
Sanofi

Sanofi May Take Mylan To Court Again Over EpiPen Antitrust Woes

Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its...
EpiPen

Mylan Defeats Sanofi’s EpiPen Antitrust Suit

Mylan has dodged claims that it unlawfully shielded its EpiPen from competition by driving Sanofi’s epinephrine auto-injector from the market through exclusive agreements with insurers and...
Enable Notifications    OK No thanks